UpdatesPress Release
Sai Parenterals' Australian subsidiary renewed an exclusive OTC supply agreement for 7½ years, valued at AUD 202 million (approx. INR 1300 Cr). This extends their partnership with leading pharmacy networks.
Sai Parenterals LimitedSAIPARENT · Filed with the exchange
No comments yet. Be the first.